HER2-IN-6
Margetuximab
Zalutumumab
Ponezumab
Lys-Arg-Thr-Leu-Arg-Arg
Nelipepimut-S
DHFR-IN-4
Zanidatamab
Seribantumab
Tomuzotuximab
Lumretuzumab
Intetumumab
Imgatuzumab
Anbenitamab
Timigutuzumab
Barecetamab
Bafisontamab
Zenocutuzumab
Cinrebafusp alfa
Petosemtamab